Gubra A S (GUBRF) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gubra A/s.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.706 -- 00:00:05.113 Welcome to the conference call. For the first part of the conference call, the participants 00:00:05.113 -- 00:00:09.740 will be in listen-only mode. During the questions and answers session, participants are 00:00:09.740 -- 00:00:15.007 able to ask questions by dialing pound key five on their telephone keypad. 00:00:15.007 -- 00:00:17.491 Now I will hand the conference over to the speakers. 00:00:17.491 -- 00:00:19.952 Please go ahead. 00:00:20.396 -- 00:00:22.699 Good morning, everybody. 00:00:22.699 -- 00:00:28.053 Welcome to our Q1 investor call. I will go through a couple 00:00:28.053 -- 00:00:34.118 of highlights of the first quarter and then hand over to the team to continue. 00:00:34.841 -- 00:00:39.987 A quick reminder, GUPA operates via a business model involving three 00:00:39.987 -- 00:00:44.192 distinct but synergistic business units. 00:00:44.192 -- 00:00:48.776 We have our biotech unit where we discover and develop 00:00:49.018 -- 00:00:54.783 peptide therapeutics and we have a validated platform with multiple 00:00:54.783 -- 00:00:56.565 obesity 00:00:56.565 -- 00:00:58.447 assets 00:00:58.447 -- 00:01:03.452 in clinical development. We have our COO, where 00:01:03.452 -- 00:01:05.413 we provide 00:01:05.413 -- 00:01:10.498 preclinical research services to external and internal customers. 00:01:10.498 -- 00:01:15.803 And we have also now established Cupra Ventures, where we invest in high-quality science 00:01:15.803 -- 00:01:21.008 adjacent to our core areas. Given I've recently received questions, I also 00:01:21.008 -- 00:01:27.020 want to be clear that Cupra Ventures is not a corporate venture fund. 00:01:27.164 -- 00:01:31.931 Coming out a record year, 2025, 00:01:31.931 -- 00:01:35.697 we have started 2026 00:...